Arkolith/Insider Trading/CORT/Form 4

Mokari Atabak

Chief Financial OfficerCORCEPT THERAPEUTICS INC (CORT) · full profile →Form 4 · filed Jun 3, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.8M
Net Open-Market Flow
-$2.8M
Transactions
6
5 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 2, 2026Tax withholding(F)395$70.44$28K16K
Jun 1, 2026Option exercise(M)40K$19.26$770K55K
Jun 1, 2026Sell(S)40K$70.00$2.8M15K
Jun 1, 2026Grant(A)634$70.44$45K16K
Jun 1, 2026Grant(A)634—$017K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 1, 2026Option exercise(M)40K—$060K

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion
S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-256011) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML